Grail Inc
GRAL
NASDAQ
Biotechnology
$67.87
USD
-0.37 (-0.54%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.05B
Volume 433.0K
Price Target
$60.00 – $60.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $60.00 and a min estimate of $60.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$60.00
-$8.6 vs prior
Implied Upside
-11.6%
-12.6% vs prior
Analyst Covering
1
-6 vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
13%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
0 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Evie Koslosky | Goldman Sachs | Hold | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
BEAM
Beam Therapeutics Inc
$26.75
▲ +0.9%
IOVA
Iovance Biotherapeutics Inc
$6.98
▲ +7.1%
NRIX
Nurix Therapeutics Inc
$27.05
▼ -0.5%
ARQT
Arcutis Biotherapeutics Inc
$26.19
▲ +1.4%
CLDX
Celldex Therapeutics Inc
$41.95
▼ -1.6%
KOD
Kodiak Sciences Inc
$41.35
▲ +3.4%
IMNM
Immunome Inc
$27.20
▲ +3.0%
IRON
Disc Medicine Inc
$78.84
▼ -1.5%
RARE
Ultragenyx Pharmaceutical Inc
$26.49
▲ +0.4%